These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 18471046)
1. Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients. Clarke JW; Chang EL; Levin VA; Mayr NA; Hong E; Cavaliere R; Lo SS Expert Rev Anticancer Ther; 2008 May; 8(5):733-41. PubMed ID: 18471046 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma. Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127 [TBL] [Abstract][Full Text] [Related]
3. Short course of radiation therapy in elderly patients with glioblastoma multiforme. Idbaih A; Taillibert S; Simon JM; Psimaras D; Schneble HM; Lopez S; Lang P; Toubiana T; Feuvret L; Delattre JY; Mazeron JJ Cancer Radiother; 2008 Dec; 12(8):788-92. PubMed ID: 19046921 [TBL] [Abstract][Full Text] [Related]
4. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme. Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132 [TBL] [Abstract][Full Text] [Related]
5. Multivariate analysis of prognostic factors in patients with glioblastoma. Lutterbach J; Sauerbrei W; Guttenberger R Strahlenther Onkol; 2003 Jan; 179(1):8-15. PubMed ID: 12540979 [TBL] [Abstract][Full Text] [Related]
6. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26). Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083 [TBL] [Abstract][Full Text] [Related]
7. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426 [TBL] [Abstract][Full Text] [Related]
8. Postoperative hypofractionated radiotherapy in glioblastoma multiforme. Arslan M; Karadeniz AN; Aksu G; Güveli M; Fayda M; Doğan AK; Akyüz F J BUON; 2006; 11(1):39-42. PubMed ID: 17318950 [TBL] [Abstract][Full Text] [Related]
9. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme. Fuller CD; Choi M; Forthuber B; Wang SJ; Rajagiriyil N; Salter BJ; Fuss M Radiat Oncol; 2007 Jul; 2():26. PubMed ID: 17629934 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy]. Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680 [TBL] [Abstract][Full Text] [Related]
11. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme. Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218 [TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019 [TBL] [Abstract][Full Text] [Related]
13. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma]. Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679 [TBL] [Abstract][Full Text] [Related]
14. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression. Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453 [TBL] [Abstract][Full Text] [Related]
15. [Results of conventional radiotherapy in malignant gliomas:]. Shibamoto Y; Yamashita J; Takahashi M; Yamasaki T; Kikuchi H; Abe M Gan No Rinsho; 1989 Sep; 35(11):1240-6. PubMed ID: 2554004 [TBL] [Abstract][Full Text] [Related]
16. Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights. Chargari C; Feuvret L; Bauduceau O; Ricard D; Cuenca X; Delattre JY; Mazeron JJ Cancer Treat Rev; 2012 Dec; 38(8):988-95. PubMed ID: 22289687 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution. Hulshof MC; Koot RW; Schimmel EC; Dekker F; Bosch DA; González González D Strahlenther Onkol; 2001 Jun; 177(6):283-90. PubMed ID: 11446316 [TBL] [Abstract][Full Text] [Related]
18. Individualized targeted therapy for glioblastoma: fact or fiction? Weller M; Stupp R; Hegi M; Wick W Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256 [TBL] [Abstract][Full Text] [Related]
19. Glioblastoma in children: a single-institution experience. Perkins SM; Rubin JB; Leonard JR; Smyth MD; El Naqa I; Michalski JM; Simpson JR; Limbrick DL; Park TS; Mansur DB Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1117-21. PubMed ID: 21220190 [TBL] [Abstract][Full Text] [Related]
20. Evolution of care for patients with relapsed glioblastoma. Balañá C; Villá S; Teixidor P Expert Rev Anticancer Ther; 2011 Nov; 11(11):1719-29. PubMed ID: 22050021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]